RESPIRA
The computed 12-month bankruptcy probability of RESPIRA is 0.3% (very low). The 2025 annual accounts show equity of €9k and a net result of €133k. Equity is shrinking by ~30.2% per year and would, assuming unchanged policy, indicatively turn negative around fiscal year 2027. Its solvency ranks better than 14% of 2209 sector peers (fiscal year 2025). The company has been active since 2022 and the Belgian State Gazette contains no insolvency or warning signals.
| Equity | €9k |
| Net result | €133k |
| Better than sector | 14% |
| Active | 3 yrs |
Strong profile, led by profitability.
All 5 axes are computed from data Checked has read.
Statistical estimate based on public sources, not credit advice nor a finding of fact. How do we compute this?
Unlock the full score breakdown, per-year score history and the indicative credit limit with Plus.
See plans →How do we compute this?
The trend is a robust median of all pairwise slopes between fiscal years (Theil-Sen), so a single odd year cannot hijack the line. For strictly positive series we also fit a log variant (compound annual growth) and keep whichever describes the figures best.
The area around the projection is 1.8 × the median absolute deviation from the trend, widening each year ahead (×1 / ×1.6 / ×2.2), with a minimum of 8% of the last value. It is an indicative range, not a statistical confidence interval.
A series whose deviations exceed 35% of its level is too volatile: we then deliberately show no projection. Every projection assumes unchanged policy and is blind to non-public information (order book, contracts, funding rounds).
| Metric | This company | Sector median | Position in the sector |
|---|---|---|---|
| Solvency | 2.8% | 58.2% | |
| Net result | €133k | €60k | |
| Equity | €9k | €74k | |
| Gross operating margin | €227k | €96k | |
| Staff costs | €34k | €22k |
| Fiscal year | 2025 |
|---|---|
| Deposit | micro |
| Revenue | - |
| EBITDA | €193k |
| Net profit | €133k |
| Cash flow | €146k |
| Staff costs | €34k |
| Income taxes | €46k |
| Dividends | €199k |
| Total assets | €323k |
| Equity | €9k |
| Debt | €313k |
| of which ≤ 1y | €313k |
| of which > 1y | - |
| Working capital | €-40k |
| Employees (FTE) | - |
| 2025 | |
|---|---|
| Current ratio | 0.87 |
| Quick ratio | 0.87 |
| Working capital ratio | -12.4% |
| Solvency | 2.8% |
| Debt / equity | 34.56 |
| Long-term debt ratio | - |
| Interest coverage | 1067.45 |
| Gross margin | - |
| Net margin | - |
| ROA | 41.1% |
| ROE | 1461.1% |
| EBITDA margin | - |
| Days sales outstanding | - |
| Days payable outstanding | - |
| Inventory turnover | - |
| Days inventory (DSI) | - |
| Line item | Code | 2025 |
|---|---|---|
| Balance sheet, Assets | ||
| TOTAL ASSETS | 20/58 | €323k |
| Fixed assets | 21/28 | €49k |
| Tangible fixed assets | 22/27 | €49k |
| Financial fixed assets | 28 | €363 |
| Current assets | 29/58 | €273k |
| Stocks & contracts in progress | 3 | €0 |
| Amounts receivable within one year | 40/41 | €34k |
| Cash & bank | 54/58 | €238k |
| Balance sheet, Equity & liabilities | ||
| TOTAL EQUITY & LIABILITIES | 10/49 | €323k |
| Equity | 10/15 | €9k |
| Contributions / capital | 10/11 | €9k |
| Accumulated profits (losses) | 14 | €71 |
| Amounts payable | 17/49 | €313k |
| Amounts payable within one year | 42/48 | €313k |
| Trade debts payable within one year | 44 | €61k |
| Income statement | ||
| Gross operating margin | 9900 | €227k |
| Operating result | 9901 | €179k |
| Financial income | 75 | €0 |
| Financial charges | 65 | €181 |
| Result before taxes | 9903 | €179k |
| Income taxes | 67/77 | €46k |
| Net result for the period | 9904 | €133k |
| Result to be appropriated | 9905 | €133k |
Former directors (1)
-
SRL MR MEDNUCLegal entityDirector· perm. rep.: MUTEGANYA RaoulState Gazette act 24456535 (30-12-2024)Former- → 17-12-2024
| NACE primary | Activiteiten van medisch specialisten(86220) |
| Legal form | Private limited company(610) |
| Incorporation | 22-10-2022 |
| Status | Active |
| Postal code | 1080 |
Parcels linked to this company through its CBE addresses (seat, establishment units, branches), cross-referenced with the cadastral parcel plan. This shows where the company operates, not a deeds register.
| Parcel (capakey) | Region | Area | Buildings | Height / fl. |
|---|---|---|---|---|
| 21524C0303/00D000 | Brussels | 1,896 m² | 1 · 767 m² | 27.2 m · 7 fl. |
A single timeline of everything that happened to this company, publications, insolvency and lifecycle events, administrative changes and filed annual accounts.
30-12-2024 MUTEGANYA Raoul resigns as director
- MUTEGANYA Raoul, Bestuurder
Technical details
{
"events": [
{
"kind": "director_out",
"role": "administrateur",
"person": {
"rrn": null,
"name": "MUTEGANYA Raoul",
"address": null,
"birth_date": null,
"profession": null,
"birth_place": null
},
"reason": "de_plein_droit_dissolution",
"subkind": "regular",
"via_org": {
"kbo": "0758.590.379",
"name": "SRL MR MEDNUC",
"address": null,
"country": null,
"legal_form": "SRL"
},
"statutory": null,
"compensated": null,
"effective_date": "2024-12-17",
"evidence_quote": "De prendre acte de la d\u00E9mission de SRL MR MEDNUC (RPM 0758.590.379), dont le repr\u00E9sentant permanent au sein de l\u2019organe d\u2019administration est Monsieur MUTEGANYA Raoul, de son mandat d\u2019administrateur, d\u00E8s ce jour.",
"decharge_status": null,
"mandate_duration": null,
"rep_rotation_new_rep": null,
"rep_rotation_old_rep": null,
"effective_date_qualifier": "immediate"
},
{
"kind": "decharge_granted",
"role": "administrateur",
"person": null,
"reason": null,
"subkind": "regular",
"via_org": null,
"statutory": null,
"compensated": null,
"effective_date": null,
"evidence_quote": "Donner d\u00E9charge irr\u00E9vocable et d\u00E9finitive \u00E0 administrateur d\u00E9missionnaire pour l\u2019exercice de son mandat d\u2019administrateur \u00E0 ce jour.",
"decharge_status": "granted",
"mandate_duration": null,
"rep_rotation_new_rep": null,
"rep_rotation_old_rep": null,
"effective_date_qualifier": null
}
],
"notary": {
"name": null,
"firm_city": null,
"firm_name": null,
"office_city": null,
"is_associated": false
},
"act_meta": {
"language": "mixed",
"pub_date": "2024-12-30",
"filing_date": "2024-12-24",
"act_kind_objet": "Objet de l\u0027acte:"
},
"decisions": [
{
"body": "decharge_granted",
"date": "2024-12-17",
"unanimous": null
}
],
"is_correction": false,
"subject_company": {
"kbo": "0792.764.766",
"name_full": "RESPIRA",
"legal_form": "SRL"
},
"publication_proxy": {
"kind": "person",
"org_kbo": null,
"org_name": null,
"person_name": "Alain GEMAYEL",
"org_rep_person_name": null,
"person_role_at_subject": null
},
"co_filed_documents": [],
"corrected_publication_numac": null
}Generate a structured, factual brief from every signal in this dossier: risk, financial health, ownership, mandates and sector comparison.
| Legal nameFR | RESPIRA |